Article Details
Retrieved on: 2022-12-15 15:39:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In a Phase 2b clinical trial, Moderna's experimental, personalized mRNA cancer vaccine combined with Merck's Keytruda immunotherapy reduced the ...
Article found on: www.advisory.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here